Brief: Panbela Therapeutics Enrolles First Patient In Phase II Trial Of Cpp-1X-T For Onset Type I Diabetes
12/04/2023 14:05
April 12 (Reuters) - Panbela Therapeutics Inc PBLA.O :
* FIRST PATIENT ENROLLED IN JDRF-FUNDED PHASE II TRIAL OF
CPP-1X-T
FOR RECENT ONSET TYPE I DIABETES, LED BY INDIANA UNIVERSITY
SCHOOL OF MEDICINE
* FIRST PATIENT ENROLLED IN JDRF-FUNDED PHASE II TRIAL OF
CPP-1X-T
FOR RECENT ONSET TYPE I DIABETES, LED BY INDIANA UNIVERSITY
SCHOOL OF MEDICINE
Source text for Eikon: ID:nGNX3nt2Gj
Further company coverage: PBLA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Panbela Therapeutics
See all newsBrief: Panbela Therapeutics Announces Third Independent Safety Review Of Phase 3 Aspire Clinical Trial DSMB Recommended Continuation With No Trial Modification
Brief: Nasdaq Notifies Panbela Therapeutics Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard
Brief: Panbela Announces Pricing of Approximately $9 Mln Public Offering
U.S. STOCKS ON THE MOVE-Fisker, Best Buy, NuStar Energy
Brief: Panbela Therapeutics Announces Exercise Of Warrants And Issuance Of New Warrants